Term: | pevonedistat |
|
Accession: | CHEBI:145535
|
browse the term
|
Definition: | A pyrrolopyrimidine that is 7H-pyrrolo[2,3-d]pyrimidine which is substituted by a (1S)-2,3-dihydro-1H-inden-1-ylnitrilo group at position 4 and by a (1S,3S,4S)-3-hydroxy-4-[(sulfamoyloxy)methyl]cyclopentyl group at position 7. It is a potent and selective NEDD8-activating enzyme inhibitor with an IC50 of 4.7 nM, and currently under clinical investigation for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes. |
Synonyms: | exact_synonym: | [(1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl]methyl sulfamate |
| related_synonym: | Formula=C21H25N5O4S; InChI=1S/C21H25N5O4S/c22-31(28,29)30-11-14-9-15(10-19(14)27)26-8-7-17-20(23-12-24-21(17)26)25-18-6-5-13-3-1-2-4-16(13)18/h1-4,7-8,12,14-15,18-19,27H,5-6,9-11H2,(H2,22,28,29)(H,23,24,25)/t14-,15+,18-,19-/m0/s1; InChIKey=MPUQHZXIXSTTDU-QXGSTGNESA-N; MLN 4924; MLN4924; SMILES=C1=CC2=C(C=C1)[C@H](CC2)NC3=C4C(=NC=N3)N(C=C4)[C@@H]5C[C@H]([C@H](C5)O)COS(N)(=O)=O; [(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxy-cyclopentyl]methyl sulfamate; pevonedistatum |
| xref: | CAS:905579-51-3; DrugBank:DB11759; KEGG:D10413; LINCS:LSM-6263 |
| xref_mesh: | MESH:C539933 |
| xref: | PDBeChem:B39; PMID:19360080; PMID:20129059; PMID:25733005; PMID:26292710; PMID:26561559; PMID:27551465; PMID:27783255; PMID:27901050; PMID:28578874; PMID:28717191; PMID:28838998; PMID:29348128; PMID:29667067; PMID:30020196; PMID:30341788; PMID:30545630; PMID:30556867; PMID:30845347; PMID:30850948; PMID:31002342; PMID:31355467; PMID:31528694; PMID:31665821; Wikipedia:Pevonedistat |
|
|